An Excellent In-House Opportunity For Transactional Attorneys
If you're a securities or M&A lawyer with five-plus years of experience, check out this job, courtesy of former ATL editor David Lat.
Goldman Sachs Asks: ‘Is Curing Patients A Sustainable Business Model?’
Will Goldman Sachs’s question reduce investments in research and development of disease cures?
Skills That Set Firms Apart
Legal expertise alone isn’t enough. Today’s most successful firms invest in developing the skills that drive collaboration, leadership, and business growth. Our on-demand, customizable training modules deliver practical, high-impact learning for attorneys and staff—when and where they need it.
The Drug Patent Two-Step
Drug companies are willing to try everything to keep their valuable patents alive.
The Government Already Has The Tools It Needs To Make Pharmaceutical Drugs Affordable — If It Really Wanted To
The government has never exercised its rights under the Bayh-Dole Act to do so.
Developing The Story Of Patent Litigation: Q&A With Cooley’s Ellen Scordino
This Biglaw partner brings pharma experience to law firm cases.
Justice Alito Looks Facts In The Face, Says, ‘Whatever.’
Justice Alito's opinion in today's death penalty case may not have been a surprise, but his unwitting undermining of conservative values was a surprise twist.
Decrypting Crypto, Digital Assets, And Web3
"Decrypting Crypto" is a go-to guide for understanding the technology and tools underlying Web3 and issues raised in the context of specific legal practice areas.
Non-Sequiturs: 05.28.15
* Nebraska banned the death penalty. Does this signal a new conservative opposition to the practice? Well, is there a way this can make private prison lobbyists more money? Because then, yes. [FiveThirtyEight] * The best way to sway a Supreme Court justice? Represent clients that the justices have financial stakes in. [Fix the Court] * Pharmaceutical companies are peeved that lawyers are using Facebook to identify class action plaintiffs. Why aren't people content to suffer grievous injury for the sake of profits anymore? [Bloomberg Business] * Now you can know for sure if your job will be replaced by a robot. Good news, lawyers! Unfortunately, I don't think this thing's taking into account document reviewers. [Postgrad Problems] * Jawbone is accusing Fitbit of poaching workers to steal its technology. Ten points to the tipster for the line: "Think this will all work out?" [Slate] * Two Biglaw partners from rival firms have joined forces on a new challenge Native American adoption rules. It helps that they're married to each other. [National Law Journal] * An interesting perspective: "innovation" is more than technology, and it starts with debt relief. [Rawr] * A former state senate candidate charged with witness tampering. At least he's got experience with the system -- his dad's political career ended in a hail of guilty pleas too. [Nashoba Publishing] * Brace yourselves for a shocker, but Biglaw is failing women. [The American Lawyer] * David Gans on the upcoming "one person, one vote" claim. The proposition at issue, that representation is based on "voters" not "persons," is so laughably unconstitutional the Court is clearly just trolling us at this point. I mean, putting aside the horrible racism, isn't the 3/5ths compromise pretty compelling evidence that the Founders meant to count people who didn't vote? [Constitutional Accountability Center]
Non-Sequiturs: 12.20.13
* A federal judge just struck down Utah’s ban on same-sex marriage. [Salt Lake Tribune] * After striking down Canada’s anti-prostitution laws, our neighbors to the North went ahead and approved a law school that functionally bans gays. What’s going on up there? Play keep away with the Stanley Cup for 20 years and they just lose their damn minds. [TaxProf Blog] * Chief Judge Alex Kozinski objects, but nobody wants to hear it. [Josh Blackman's Blog] * Professor Richard Sander won the right to examine law school race, attendance and grade information, in a bid to prove his central theory that affirmative action somehow hurts black folks. I guess the California Supreme Court is on Team Sander. [San Jose Mercury News] * Amy Schulman, the powerful general counsel at Pfizer, is out — and now there’s some interesting speculation as to why. [Law and More] * So now everyone’s writing legal opinions over Fantasy Football trades. [BigLaw Rebel] * Jim Harbaugh gets all his legal acumen from Judge Judy. Next thing you know he’ll be objecting to “What’s your deal?” for lack of foundation. [ESPN] * Speaking of Jennifer Lawrence, she can probably help with your International Law final. [The Onion] * There’s a rundown of the top patent law stories of 2013 on the web next month. And there’s CLE to be had! [Patently-O]
Using Patents To Needlessly Drive Up Healthcare Costs: The Economic Impact Of Evergreening Drugs
That "New and Improved" drug coming off patent might just be a cheap trick to get another patent.
When Buying Off A Litigant Is Also Buying Off A Competitor
According to the Supreme Court, sometimes settling a lawsuit can create an antitrust problem. How?
[E-BOOK] 5 AI Productivity Hacks To Save Time And Streamline Your Law Firm
Discover five practical ways to harness AI and eliminate busywork—so you can focus more on your clients and less on repetitive tasks.
Inside Straight: Learning Who To Hate
Cops learn to hate people. Basically everyone they encounter is a criminal, so cops soon come to believe that everyone is a criminal. Litigators — or perhaps litigators who are repeat players in a particular field — learn to hate people. Personal injury insurance defense counsel come to believe that all plaintiffs are lying fakers. […]
Inside Straight: Pfortune On Pfizer
Columnist Mark Herrmann thinks that you should read the long piece in Fortune magazine about the rise and fall of Jeff Kindler as the CEO of Pfizer because it gives some insight on life as an in-house attorney....
Skaddenfreude: In-House Salaries, Please
This item, from yesterday’s WSJ Law Blog, caught our eye: As the 11th Vioxx trial got underway yesterday in federal court in New Orleans, Merck disclosed in an SEC filing that it’s giving its general counsel Kenneth Frazier a raise and a promotion, effective Nov. 1. The GC who will forever be associated with the […]